Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

Aegerion Pharmaceuticals

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
Cambridge, Massachusetts, United States Founded 2005 101-250 employees For Profit

Aegerion Pharmaceuticals engages in the development of therapeutics and pharmaceuticals to treat cardiovascular and metabolic diseases.

Aegerion Pharmaceuticals on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

Aegerion Pharmaceuticals was acquired by Amryt Pharma in 2019.
Total Funding
$45.36M
Funding Rounds
4
Last Funding
Acquisitions
1
Monthly Visits
Contacts
9
Patents
7
4 trademarks

About Aegerion Pharmaceuticals

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Delisted
Ticker
AEGR
Exchange
NASDAQ
IPO date
Oct 22, 2010
Raised at IPO
$47.5M
Delisted
May 21, 2019

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
8
Active products
17
Patents granted
7
Trademarks
4
Top patent class
Medical Or Veterinary Science; Hygiene

Company Info

Founded
2005
Employees
101-250
Operating status
Closed
Company type
For Profit
Org types
company
News articles
63
HQ
Cambridge, Massachusetts, United States
Region
Greater Boston Area, East Coast, New England
Diversity spotlight
Women Led
Exit date
Oct 22, 2010

Signals & Scores

Heat score
Low
Trend (7d)
-0.1
Trend (30d)
-1
Trend (90d)
-1.6

Aegerion Pharmaceuticals Funding Rounds

4 results
Upgrade to Pro to view this datasetUpgrade
Organization NameFunding TypeLead Investor NamesInvestor NamesFunding StageOrg IndustriesOrg Hq CityOrg Hq CountryOrg DescriptionOrg Number Of EmployeesOrg Website
1–4 of 4Show
Page 1 / 1

Aegerion Pharmaceuticals Acquisitions

1 results
Acquiree NameAcquirer NameAcquisition TypeAcquisition TermsAcquiree IndustriesAcquiree Hq CityAcquiree Hq CountryAcquiree DescriptionAcquiree Number Of EmployeesAcquirer IndustriesAcquirer Hq CountryAcquirer Number Of EmployeesAcquirer Ipo StatusAcquiree Website
Myalept2014-11-06Aegerion PharmaceuticalsAcquisitionHealth CareMedicalA product designed to treat complications of leptin deficienBiotechnologyHealth CareTherapeuticsUnited States101-250Delisted1myalept.com/
1–1 of 1Show
Page 1 / 1

Aegerion Pharmaceuticals Key People

Board of Directors
9
professional contacts at Aegerion Pharmaceuticals
Contact execs at Aegerion Pharmaceuticals

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

Recent News related to Aegerion Pharmaceuticals

Loading news…

FAQs about Aegerion Pharmaceuticals

People who checked this page also checked these

Sectors Aegerion Pharmaceuticals invests & acquires in

M&A by year

Browse the full Acquirezy directory.